Similar articles

• The value of atypical antipsychotics in the treatment of schizophrenia.

  Jessen LM. Jessen LM. Manag Care. 2002 Jul;11(7 Suppl):8-12; discussion 12-3. Manag Care. 2002. PMID: 12181875 No abstract available.
• The new antipsychotic compounds: is a clinical choice algorithm possible?

  Wirshing WC. Wirshing WC. West J Med. 1998 Jul;169(1):43-4. West J Med. 1998. PMID: 9682633 Free PMC article. No abstract available.
• Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.

  Kelly DL, Kreyenbuhl J, Love RC, Van-Duong Q, Conley RR. Kelly DL, et al. J Clin Psychiatry. 2003 Sep;64(9):1133-4. doi: 10.4088/jcp.v64n0921f. J Clin Psychiatry. 2003. PMID: 14628994 No abstract available.
• Antipsychotic drug side effect issues in bipolar manic patients.

  Zarate CA Jr. Zarate CA Jr. J Clin Psychiatry. 2000;61 Suppl 8:52-61; discussion 62-3. J Clin Psychiatry. 2000. PMID: 10811244 Review.
• [Atypical antipsychotic drugs].

  Kahn RS. Kahn RS. Ned Tijdschr Geneeskd. 2000 Aug 19;144(34):1627-30. Ned Tijdschr Geneeskd. 2000. PMID: 10972052 Review. Dutch.